IMG_1896_edited.jpg

The Cancer Vaccine Institute (CVI) of the University of Washington (UW) Department of Medicine, Division of Medical Oncology is located at the UW Medicine at South Lake Union campus. The CVI is comprised of a translational research environment that includes laboratory, clinical research, and administrative office areas. Work is typically deadline driven and requires a high level of accuracy, extensive communication with scientists, staff, and external collaborators from diverse backgrounds.

As UW employees, our team has a unique opportunity to change lives on our campuses, in our state, and around the world. UW employees are known for their boundless energy, creative problem solving skills, and dedication to building stronger minds and a healthier world.

UW faculty and staff also enjoy outstanding benefits, professional growth opportunities, and unique resources in an environment noted for diversity, intellectual excitement, artistic pursuits and natural beauty. All of which has allowed the UW to be nationally recognized as a “Great College to Work For” for six consecutive years.

Join Our Team

"We will only make great strides if we get the best minds into the Institute, and we really think disruptively and creatively. The best way you can do that is by constantly shaking things up by bringing new people into the mix."

— Dr. Nora Disis, CVI Director

Open Positions

Postdoctoral Scholar - Cancer and Autoimmunity

The University of Washington Medicine Cancer Vaccine Institute, Department of Medicine, Division of Medical Oncology is recruiting for a post-doctoral fellow to study the intersection of cancer and autoimmunity with a focus on chronic inflammatory diseases that may predispose people to the development of cancer. This is a full-time, 12-month term position with possible extension to another 12-months depending on performance. The position would be at the Postdoctoral Scholar level. The project is highly translational and entails the identification of immunogenic proteins and deep phenotyping of the T-cell response in both humans and a variety of mouse models. Data generated will lead to the development of vaccines and other forms of immune therapy to limit inflammation. This project will use in vivo modeling of immune therapies in transgenic mouse models of autoimmune disease to assess vaccine efficacy and interrogate the mechanism of action of immunization via evaluating vaccine-induced T-cell function and immunophenotyping.

Postdoctoral Scholar - Colon Cancer Vaccine Development

The Cancer Vaccine Institute recruiting a full-time postdoctoral fellow to work on the development of vaccines for the prevention and treatment of colon cancer. This is a full-time, 12-month term position with possible extension to another 12-months depending on funding and performance. The position would be at the Postdoctoral Scholar level. The project is highly translational and entails the identification of immunogenic proteins to target with cancer vaccines, as well as in vivo modeling of immune therapies in transgenic mouse models of adenomas and colon cancers. Analyzing novel combinations of immune stimulating drugs with vaccines is another element of the project.